Cardiac Resynchronization Therapy Market Introduction

Cardiac Resynchronization Therapy Market is estimated to value over USD 4.8 billion by 2027 end and register a CAGR of over 4% during the forecast period 2020 to 2027.

The CRT-D products are projected to lead the market during the forecast period. As per the published paper from the Journal of Cardiovascular Electrophysiology, over half of the CRT product implants are performed using CRT-D. Latin America and the Asia Pacific region are projected to exhibit profitable growth and account for over 25.0% of the total revenue in 2025. This has been credited to the rapid industrial expansion by key market players concerning distribution as well as manufacturing. 

A necessity for high optimization of operations and competitive pricing are projected to assist companies to establish their position in developing economies such as Mexico, India and others. In addition, countries like Japan are observed to record a higher adoption rate for quadripolar lead-based CRT-D devices. This is projected to further stimulate market growth.

Based on end-user, the market is fragmented into ambulatory surgery centres and hospitals and cardiac centres. Hospitals and cardiac centres held the largest  market share in 2019. A rising number of surgical procedures performed, increasing number of critical care and intensive care units, the increasing prevalence of CVD and favourable reimbursement scenario are some of the key factors driving the growth of the segment.

The Asia Pacific region is predicted to record the highest growth rate in the market during the forecast period. The rising geriatric population in China, rising incidence of CVDs, growing middle-class population, favourable reimbursement scenario in Japan, rising disposable income levels in India and improving healthcare infrastructure are some of the important factors steering the cardiac resynchronization therapy market growth in the Asia Pacific region.


Key market players included in the cardiac resynchronization therapy industry are Medtronic Plc, Abbott Laboratories, Boston Scientific Corp., Biotronik, Medico S.P.A, Microport Scientific Corp. 

Cardiac Resynchronization Therapy Market

Global Cardiac Resynchronization Therapy Market Segmentation:

By Type

· Cardiac Resynchronization Therapy Defibrillators 

· Cardiac Resynchronization Therapy Pacemakers 


By End User

· Hospitals & Cardiac Centers 

· Ambulatory Surgery Centers 


By Region

· North America

· Europe

· Asia Pacific

· Rest of the World


FutureWise Key Takeaways:

 • Growth prospects

• SWOT analysis 

• Key trends 

• Key data-points affecting market growth 


Objectives of the Study:

  • To provide with an exhaustive analysis on the global cardiac resynchronization therapy market by type, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and the rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics